Document is current
Any future updates will be listed below
-
Authors
Plessis, Amy
Cook, Victoria E.
Erdle, Stephanie C.
Chan, Edmond S.
- License Information
-
More Information
Article History
Received: 16 December 2025
Accepted: 29 March 2026
First Online: 17 April 2026
Declarations
:
: This retrospective survey review. This study did not warrant formal ethics review, as the University of British Columbia categorized it as quality improvement.
: Not applicable.
: AP: has no conflicts of interest to declare. VEC: has been on advisory boards for ALK, Celltrion, and has received grant support from Celltrion. SCE: has received a research grant from Avir-Pharma and an educational grant from Pfizer and has been a member of an advisory board for ALK and BioCryst. ESC: has participated in clinical trials for DBV Technologies and ALK-Abello, has been a member of advisory boards for ALK, Bausch Health, Celltrion, Incyte, Novartis, Sanofi, Viatris and was co-lead of the CSACI oral immunotherapy guidelines.
